Psychiatry and Neurology, Neurology · Oklahoma City, OK
NPI
1487212718
Since 2019
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
4120 W Memorial Rd Ste 218
Oklahoma City, OK, 73120
Phone (405) 302-2661
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
5,620 services
Medicare patients, 2024
181
Average age 74
Drug cost, 2024
$621K
382 prescriptions
Company payments, 2025
$4,831
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicole C Bowden was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 188 times for 102 patients. In total Nicole C Bowden billed 5,620 services in 21 codes, and Medicare paid $68K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 188 | 102 | $12.15 | $2,284 |
| 99214 Office E&M - Established | Office | 134 | 81 | $88.90 | $12K |
| 99204 Office E&M - New | Office | 73 | 73 | $110.00 | $8,030 |
| 99205 Office E&M - New | Office | 52 | 52 | $149.20 | $7,758 |
| 99215 Office E&M - Established | Office | 47 | 41 | $117.80 | $5,537 |
| 99213 Office E&M - Established | Office | 31 | 28 | $63.58 | $1,971 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 21 | 16 | $22.89 | $481 |
By year: 2023 $10K for 661 services; 2024 $68K for 5,620 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nicole C Bowden prescribed most often to Medicare patients was Emgality Pen (Galcanezumab-Gnlm), with 37 prescriptions and refills. In total Nicole C Bowden wrote 382 Medicare prescriptions that cost $621K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Emgality Pen Galcanezumab-Gnlm | 37 | 41 | Under 11 | $30K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 34 | 70 | 12 | $960 |
| Propranolol Hcl Er Propranolol Hcl | 30 | 61 | 11 | $590 |
| Lacosamide Generic | 30 | 32 | Under 11 | $2,559 |
| Rystiggo Rozanolixizumab-Noli | 20 | 20 | Under 11 | $437K |
| Levetiracetam Generic | 20 | 22 | Under 11 | $394 |
| Memantine Hcl Generic | 18 | 27 | Under 11 | $298 |
| Topiramate Generic | 16 | 21 | Under 11 | $81.49 |
| Rytary Carbidopa/Levodopa | 16 | 16 | Under 11 | $18K |
| Propranolol Hcl Generic | 14 | 24 | Under 11 | $237 |
| Ubrelvy Ubrogepant | 13 | 13 | Under 11 | $19K |
| Nurtec Odt Rimegepant Sulfate | 11 | 11 | Under 11 | $21K |
Brand drugs: 113 claims; generic drugs: 269 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicole C Bowden $4,831 ($4,831 in general payments such as food, travel and fees) from 35 companies. The largest payer was Abbvie Inc. with $751.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 63 | $751 |
| Teva Pharmaceuticals USA, Inc. TEVA | 19 | $427 |
| Pfizer Inc. PFE | 23 | $337 |
| Lundbeck LLC | 17 | $323 |
| UCB, Inc. UCB.BR | 18 | $320 |
| SK Life Science, Inc. | 10 | $225 |
| TG Therapeutics, Inc. TGTX | 11 | $211 |
| Eisai Inc. 4523.T | 10 | $204 |
| ACADIA Pharmaceuticals Inc ACAD | 15 | $201 |
| Neurocrine BioSciences, Inc. NBIX | 10 | $177 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.